LU92748I2 - Virus de la diarrhée virale bovine atténué 2 (bvdv-2) - Google Patents

Virus de la diarrhée virale bovine atténué 2 (bvdv-2) Download PDF

Info

Publication number: LU92748I2
Authority: LU; Luxembourg
Prior art keywords: bvdv; diarrhea virus; bovine viral; viral diarrhea; attenuated bovine
Prior art date: 2004-05-19

Application number

LU92748C

Other languages

English (en)

Original Assignee

Boehringer Ingelheim Vetmdica Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-19

Filing date

2015-06-19

Publication date

2015-11-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92748(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-06-19 Application filed by Boehringer Ingelheim Vetmdica Gmbh filed Critical Boehringer Ingelheim Vetmdica Gmbh

2015-11-02 Publication of LU92748I2 publication Critical patent/LU92748I2/fr

Links

241000530623 Bovine viral diarrhea virus 2 Species 0.000 title 2
230000002238 attenuated effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Mycology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LU92748C 2004-05-19 2015-06-19 Virus de la diarrhée virale bovine atténué 2 (bvdv-2) LU92748I2 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102004025452A DE102004025452A1 (de)	2004-05-19	2004-05-19	Vakzine enthaltend BVDV

Publications (1)

Publication Number	Publication Date
LU92748I2 true LU92748I2 (fr)	2015-11-02

Family

ID=34967522

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
LU92749C LU92749I2 (fr)	2004-05-19	2015-06-19	Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)
LU92748C LU92748I2 (fr)	2004-05-19	2015-06-19	Virus de la diarrhée virale bovine atténué 2 (bvdv-2)
LU92747C LU92747I2 (fr)	2004-05-19	2015-06-19	Virus de la diarrhée bovine atténué 1 (bvdv-1)

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
LU92749C LU92749I2 (fr)	2004-05-19	2015-06-19	Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
LU92747C LU92747I2 (fr)	2004-05-19	2015-06-19	Virus de la diarrhée bovine atténué 1 (bvdv-1)

Country Status (26)

Country	Link
EP (1)	EP1751276B9 (fr)
JP (2)	JP5006782B2 (fr)
KR (1)	KR100908798B1 (fr)
CN (2)	CN103352030B (fr)
AR (2)	AR049176A1 (fr)
AT (1)	ATE420949T1 (fr)
AU (1)	AU2005243488B2 (fr)
BR (1)	BRPI0510396B1 (fr)
CA (1)	CA2561719C (fr)
CY (4)	CY1109036T1 (fr)
DE (2)	DE102004025452A1 (fr)
DK (1)	DK1751276T5 (fr)
ES (1)	ES2321210T3 (fr)
FR (3)	FR15C0044I2 (fr)
HU (2)	HUS1500033I1 (fr)
LU (3)	LU92749I2 (fr)
ME (1)	ME01119B (fr)
MX (1)	MXPA06013298A (fr)
NL (3)	NL300743I1 (fr)
NZ (1)	NZ552088A (fr)
PL (1)	PL1751276T3 (fr)
PT (1)	PT1751276E (fr)
RS (1)	RS50753B9 (fr)
SI (1)	SI1751276T1 (fr)
UY (1)	UY28905A1 (fr)
WO (1)	WO2005111201A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7179473B2 (en)	1998-06-05	2007-02-20	Boehringer Ingelheim Vetmedica Gmbh	Attenuated pestiviruses
US7135561B2 (en)	2001-09-06	2006-11-14	Boehringer Ingelheim Vetmedica Gmbh	Infectious bovine viral diarrhea virus clone
US20090068223A1 (en)	2005-11-15	2009-03-12	Boehringer Ingelheim Vetmedica, Inc.	Combination vaccine comprising an attenuated bovine viral diarrhea virus
CL2007002704A1 (es)	2006-09-22	2008-05-30	Intervet Int Bv	Mutante de un pestivirus de una cepa citopatogenica con deleciones en la region codificante de la proteina npro del virus; vacuna que la comprende; y su uso para proteger al ganado vacuno contra la infeccion con un pestivirus tipo silvestre.
CL2008003202A1 (es)	2007-10-29	2009-11-27	Boehringer Ingelheim Vetmedica Inc	Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) *	2008-06-25	2010-01-29	Boheringer Ingelheim Pharma Kg	Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
SG10201506597RA (en)	2008-10-31	2015-10-29	Boehringer Ingelheim Vetmed	Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
US8846054B2 (en)	2009-01-09	2014-09-30	Boehringer Ingelheim Vetmedica, Inc.	Method of treating pregnant cows and/or heifers
UY32570A (es)	2009-04-24	2010-11-30	Boehringer Ingelheim Vetmed	Vacuna viva modificada de mycoplasma bovis mejorada
BR112013006515B1 (pt)	2010-09-21	2020-04-28	Intervet Int Bv	vacina de combinação, e, método para a fabricação de uma vacina de combinação
JP6589159B2 (ja) *	2014-04-01	2019-10-16	共立製薬株式会社	新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
ES2757927T3 (es) *	2014-05-23	2020-04-30	Boehringer Ingelheim Vetmedica Gmbh	Virus de la peste porcina clásica (VPPC) recombinante que comprende sustituciones en el epítopo TAV de la proteína E2
CN105779499B (zh) *	2016-03-23	2019-11-19	江苏科技大学	重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) *	2017-11-10	2020-10-02	齐鲁动物保健品有限公司	牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) *	2018-04-18	2021-07-13	中国科学院武汉病毒研究所	猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) *	2022-05-24	2023-06-13	中国农业科学院兰州兽医研究所	一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847B (zh) *	2023-01-11	2024-06-14	青岛大学	小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6168942B1 (en) *	1998-11-10	2001-01-02	Pfizer Inc.	Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (fr) *	1999-11-30	2001-06-06	Boehringer Ingelheim Vetmedica Gmbh	Virus de la diarrhée des bovins surs attenués pour utilisation chez des vaches gravides
CA2363493C (fr) *	2000-11-22	2006-06-06	Xuemei Cao	Virus de la diarrhee virale bovine de formes attenuees
DE10143813A1 (de) *	2001-09-06	2003-04-10	Boehringer Ingelheim Vetmed	Infektiöser Rindervirusdiarrhoe-Virusklon

2004
- 2004-05-19 DE DE102004025452A patent/DE102004025452A1/de not_active Withdrawn
2005
- 2005-05-18 CN CN201310269097.1A patent/CN103352030B/zh not_active Expired - Lifetime
- 2005-05-18 AR ARP050102032A patent/AR049176A1/es active IP Right Grant
- 2005-05-18 AT AT05741681T patent/ATE420949T1/de active
- 2005-05-18 NZ NZ552088A patent/NZ552088A/en not_active IP Right Cessation
- 2005-05-18 SI SI200530619T patent/SI1751276T1/sl unknown
- 2005-05-18 KR KR1020067026800A patent/KR100908798B1/ko not_active Expired - Lifetime
- 2005-05-18 WO PCT/EP2005/005377 patent/WO2005111201A1/fr not_active Ceased
- 2005-05-18 PL PL05741681T patent/PL1751276T3/pl unknown
- 2005-05-18 EP EP05741681.0A patent/EP1751276B9/fr not_active Expired - Lifetime
- 2005-05-18 DK DK05741681.0T patent/DK1751276T5/da active
- 2005-05-18 JP JP2007517077A patent/JP5006782B2/ja not_active Expired - Lifetime
- 2005-05-18 DE DE602005012381T patent/DE602005012381D1/de not_active Expired - Lifetime
- 2005-05-18 CN CN200580024345XA patent/CN1989240B/zh not_active Expired - Lifetime
- 2005-05-18 ME MEP-2009-56A patent/ME01119B/me unknown
- 2005-05-18 UY UY28905A patent/UY28905A1/es not_active IP Right Cessation
- 2005-05-18 ES ES05741681T patent/ES2321210T3/es not_active Expired - Lifetime
- 2005-05-18 MX MXPA06013298A patent/MXPA06013298A/es active IP Right Grant
- 2005-05-18 CA CA2561719A patent/CA2561719C/fr not_active Expired - Lifetime
- 2005-05-18 RS RS20090106A patent/RS50753B9/sr unknown
- 2005-05-18 PT PT05741681T patent/PT1751276E/pt unknown
- 2005-05-18 BR BRPI0510396-7A patent/BRPI0510396B1/pt active IP Right Grant
- 2005-05-18 AU AU2005243488A patent/AU2005243488B2/en not_active Expired
2009
- 2009-04-10 CY CY20091100429T patent/CY1109036T1/el unknown
2011
- 2011-11-11 JP JP2011247652A patent/JP5562316B2/ja not_active Expired - Lifetime
2015
- 2015-06-16 NL NL300743C patent/NL300743I1/nl unknown
- 2015-06-16 NL NL300744C patent/NL300744I2/nl unknown
- 2015-06-16 NL NL300745C patent/NL300745I1/nl unknown
- 2015-06-19 FR FR15C0044C patent/FR15C0044I2/fr active Active
- 2015-06-19 CY CY2015023C patent/CY2015023I2/el unknown
- 2015-06-19 LU LU92749C patent/LU92749I2/fr unknown
- 2015-06-19 FR FR15C0043C patent/FR15C0043I2/fr active Active
- 2015-06-19 CY CY2015022C patent/CY2015022I2/el unknown
- 2015-06-19 LU LU92748C patent/LU92748I2/fr unknown
- 2015-06-19 FR FR15C0042C patent/FR15C0042I2/fr active Active
- 2015-06-19 CY CY2015021C patent/CY2015021I2/el unknown
- 2015-06-19 HU HUS1500033C patent/HUS1500033I1/hu unknown
- 2015-06-19 LU LU92747C patent/LU92747I2/fr unknown
- 2015-06-19 HU HUS1500031 patent/HUS1500031I1/hu unknown
2016
- 2016-04-28 AR ARP160101219A patent/AR104448A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP5562316B2 (ja)	2014-07-30
FR15C0043I1 (fr)	2015-07-24
AU2005243488B2 (en)	2011-07-07
WO2005111201A1 (fr)	2005-11-24
CA2561719A1 (fr)	2005-11-24
CN1989240A (zh)	2007-06-27
CA2561719C (fr)	2015-01-27
UY28905A1 (es)	2005-12-30
FR15C0042I1 (fr)	2015-07-24
NL300743I2 (fr)	2016-01-26
ME01119B (me)	2013-03-20
LU92749I2 (fr)	2015-11-02
AU2005243488A1 (en)	2005-11-24
EP1751276B9 (fr)	2020-05-27
DK1751276T3 (da)	2009-05-18
CN103352030B (zh)	2018-08-10
RS50753B9 (sr)	2020-08-31
BRPI0510396A (pt)	2007-11-13
CY2015023I2 (el)	2024-02-16
EP1751276B1 (fr)	2009-01-14
MXPA06013298A (es)	2007-05-07
PT1751276E (pt)	2009-02-24
AR104448A2 (es)	2017-07-19
DK1751276T5 (da)	2020-07-20
BRPI0510396B1 (pt)	2020-08-18
AR049176A1 (es)	2006-07-05
DE602005012381D1 (de)	2009-03-05
NL300744I1 (fr)	2016-01-26
LU92747I2 (fr)	2015-11-02
KR100908798B1 (ko)	2009-07-22
FR15C0043I2 (fr)	2016-05-27
HUS1500033I1 (hu)	2015-07-28
NL300744I2 (fr)	2016-01-26
CY2015021I2 (el)	2023-11-15
CY2015022I1 (el)	2020-05-29
CY1109036T1 (el)	2014-07-02
NZ552088A (en)	2009-10-30
FR15C0042I2 (fr)	2018-11-16
CY2015021I1 (el)	2020-05-29
ATE420949T1 (de)	2009-01-15
NL300745I2 (fr)	2016-01-26
SI1751276T1 (sl)	2009-06-30
JP5006782B2 (ja)	2012-08-22
CN103352030A (zh)	2013-10-16
CN1989240B (zh)	2013-07-31
CY2015022I2 (el)	2024-02-16
JP2012061001A (ja)	2012-03-29
ES2321210T3 (es)	2009-06-03
FR15C0044I2 (fr)	2016-05-27
CY2015023I1 (el)	2020-05-29
RS50753B (sr)	2010-08-31
DE102004025452A1 (de)	2006-01-19
KR20070012862A (ko)	2007-01-29
NL300743I1 (fr)	2016-01-26
PL1751276T3 (pl)	2009-06-30
EP1751276A1 (fr)	2007-02-14
ES2321210T9 (es)	2020-11-04
JP2007537740A (ja)	2007-12-27
NL300745I1 (fr)	2016-01-26
FR15C0044I1 (fr)	2015-07-24
HUS1500031I1 (hu)	2019-11-28

Publication	Publication Date	Title
LU92747I2 (fr)	2015-11-02	Virus de la diarrhée bovine atténué 1 (bvdv-1)
EP1948229A4 (fr)	2011-06-15	Vaccin combiné comprenant un virus atténué de la diarrhée virale bovine
NO2012018I2 (no)	2012-11-21	Canakinumab eller direkte ekvivalenter derav
DK2206517T3 (da)	2023-11-06	Immunpotentierende sammensætninger omfattende af anti-PD-L1-antistoffer
NO20044326D0 (no)	2004-10-12	Virale antigener
GB0718984D0 (en)	2007-11-07	Structure of the hepatitis C virus NS5A protein
DK1252824T3 (da)	2006-10-02	Fremgangsmåde til forbedring af knoglemineralisering
AU2003254594A8 (en)	2005-01-28	Methods and compositions for detecting sars virus and other infectious agents
PL368370A1 (pl)	2005-03-21	Kompozycja glifosatu
NO20030239L (no)	2003-03-18	Modifisert virus
DE60224595D1 (de)	2008-02-21	Fluoroelastomere
EP1723238A4 (fr)	2007-07-04	Virus oncolytiques modifies
DE60218117D1 (de)	2007-03-29	Vorverzerrungsschaltung
ZA200803558B (en)	2009-09-30	Marked bovine viral diarrhea virus vaccines
EP1692279A4 (fr)	2006-12-27	Preparations de virus contenant un conservateur
DE60223614D1 (de)	2008-01-03	Weichmacherzusammensetzung
NO20041984L (no)	2004-05-13	Stenter
DE60203066D1 (de)	2005-04-07	Weichmacherzusammensetzung
DK1749885T3 (da)	2013-03-11	Infektiøs og svækket kvægdiarévirus
DK1238587T3 (da)	2005-11-14	Biopesticidpræparater
ATA6842001A (de)	2005-12-15	Tank
DE60216645D1 (de)	2007-01-18	Antiulcus pflanzenzusammensetzung(en)
DE50301116D1 (de)	2005-10-06	9-alpha-substituierte estratriene als selektiv wirksame estrogene
DE60226536D1 (de)	2008-06-26	Weichmacherzusammensetzung
EP1539938A4 (fr)	2007-11-28	Virus gb-b (gbv-b) chimerique